Zinc and Cancer: A Trace Mineral’s Expansive Role in Tumor Biology and Immune Defense

Evidence-Based Insights into Zinc’s Anticancer Mechanisms, Clinical Applications, Testing Methods, and Supplementation Strategies

Researched and written by Keith Bishop, Clinical Nutritionist, Cancer Coach, Retired Pharmacist, and Founder of Prevail Over Cancer

Zinc is an essential micronutrient that plays a crucial role in the metabolism of proteins, lipids, and nucleic acids, as well as in gene transcription. This micronutrient is critical for numerous physiological processes, including reproduction, immune function, and wound healing. At the cellular level, zinc is indispensable for the normal function of the immune system’s macrophages, neutrophils, natural killer cells, and the complement system. Zinc is a micronutrient, so it is not well stored in the body and has to be frequently replenished.

Zinc is an essential trace mineral involved in hundreds of biological processes that sustain cellular health, immune resilience, and metabolic balance. It serves as a cofactor for over 300 enzymes, influencing DNA synthesis, protein folding, and antioxidant defense mechanisms. Zinc also plays a pivotal role in immune modulations supporting thymic hormone activity, T-cell maturation, and cytokine regulation. In the nervous system, zinc plays a crucial role in synaptic transmission and neurogenesis, with deficiency associated with cognitive decline and mood disorders. Its structural role in zinc-finger proteins further enables gene expression and cell signaling, making zinc indispensable for tissue repair, growth, and defense against cancer.

Anticancer Mechanisms of Zinc

Zinc influences cancer biology through multiple pathways:

• DNA Repair and Genomic Stability: Zinc is a cofactor for DNA repair enzymes and zinc-finger transcription factors, including p53, which regulates apoptosis (cancer cell death) and cell cycle arrest (division of one cell into two).
• Oxidative Stress Modulation: Zinc stabilizes cell membranes and inhibits NADPH oxidase, reducing reactive oxygen species (ROS) and lipid peroxidation.
• Epigenetic Regulation: Zinc ions reduce CpG methylation in promoter regions of metallothionein genes, enhancing their expression and suppressing tumor aggressiveness in esophageal squamous cell carcinoma.
• Apoptosis Induction: Zinc activates caspases and enhances mitochondrial membrane permeability, promoting apoptosis (cell death) in cancer cells.
• Anti-inflammatory Effects: Zinc downregulates NF-κB and IL-6, reducing chronic inflammation linked to tumor progression.
• Angiogenesis Inhibition: Zinc suppresses VEGF expression and endothelial cell proliferation, limiting tumor vascularization.
• Immune Surveillance Enhancement: Zinc boosts cytotoxic T-cell and NK cell activity, improving immune-mediated tumor clearance.

Cancers Studied in Zinc Research

Zinc has been investigated in relation to the following cancers:

• Bladder Cancer
• Breast Cancer
• Cervical Cancer
• Colorectal Cancer
• Esophageal Cancer
• Head and Neck Cancer
• Hepatocellular Carcinoma
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer
• Skin Cancer (Melanoma)
• Stomach (Gastric) Cancer

Zinc’s Role in Cancer Immune Support

Zinc is essential for:

• Thymic Hormone Activity: Zinc-dependent thymulin regulates T-cell maturation.
• Cytokine Balance: Zinc modulates IL-2, IFN-γ, and TNF-α, enhancing immune coordination.
• Barrier Integrity: Zinc maintains epithelial and mucosal defenses, reducing infection risk during chemotherapy.
• Antibody Production: Zinc supports B-cell differentiation and immunoglobulin synthesis.

Zinc’s Role in Neuroprotection in Cancer Treatments

 Zinc plays a vital role in maintaining neurological integrity, particularly in cancer patients vulnerable to cognitive decline, mood disturbances, and treatment-induced neurotoxicity. It is concentrated in the hippocampus and cerebral cortex, where it modulates synaptic transmission, neurogenesis, and plasticity—key processes for memory and emotional regulation. Zinc acts as a neuromodulator at glutamatergic and GABAergic synapses, influencing NMDA receptor activity and protecting against excitotoxicity.

In the context of cancer, zinc deficiency has been linked to elevated neuroinflammatory markers such as IL-1β, TNF-α, and NF-κB, which contribute to fatigue, depression, and cognitive impairment—especially during chemotherapy and radiation therapy. Zinc’s antioxidant properties help mitigate oxidative damage in the brain, counteracting the neurotoxic effects of reactive oxygen species generated by cancer treatments.

Moreover, low zinc status has been associated with increased risk of depression and anxiety in oncology populations, likely due to impaired serotonin synthesis and HPA axis dysregulation. Maintaining optimal zinc levels may therefore support cognitive resilience, emotional stability, and overall quality of life during and after cancer therapy.

Symptoms of Elevated Zinc Levels

While zinc is essential, excessive intake—especially above the tolerable upper intake level of 40 mg/day—can lead to toxicity. Acute symptoms include nausea, vomiting, diarrhea, abdominal pain, and headaches (Healthline, 2025; Medical News Today, 2025). Chronic overexposure may result in copper deficiency, anemia, suppressed immune function, low HDL cholesterol, and even nerve damage (SingleCare, 2025). Industrial exposure (e.g., welding fumes) can trigger metal fume fever, a short-lived condition with flu-like symptoms. Monitoring intake and avoiding stacking zinc-containing products is essential.

🧾 Zinc Deficiency vs. Zinc Excess: Symptom Comparison

Zinc Testing Methods

• Zinc Taste Test: A qualitative screening tool using zinc sulfate solution. A strong metallic taste suggests sufficiency; absence may indicate deficiency.
  • Flourish Nutrition Assessment Pack: Urine and Saliva pH, Zinc Taste Test, and Iodine Paint 
  • Zinc Taste Test Drops: at home test - Amazon Link
• Plasma Copper-Zinc Ratio: A robust marker of oxidative stress and inflammation. Ideal ratio: 0.7–1.0. Elevated copper and low zinc may signal cancer risk.
  • Zinc Plasma Test - Ulta Labs
  • Comprehensive Toxic & Essential Elements Profile by ZRT Laboratory
  • Zinc, Copper and Ceruloplasmin Panel - Ulta Labs

 
Learn How to Select a Quality Dietary Supplement

Ranking Zinc Absorption Forms

My Favorite Zinc Supplements for Cancer Challenges

Zinc Glycinate 20mg by Xymogen

Zinc Glycinate 30mg by NuMedica

Zinc Lozenge 15mg by Seeking Health

Zinc and Cancer Reference Sources

Baddam S, Maxfield L, Shukla S, et al. Zinc Deficiency. [Updated 2025 Aug 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493231/

Kiouri, D.P., Chasapis, C.T., Mavromoustakos, T. et al. Zinc and its binding proteins: essential roles and therapeutic potential. Arch Toxicol 99, 23–41 (2025). https://doi.org/10.1007/s00204-024-03891-3

Dai G, Phalen S, McMurray DN. Nutritional modulation of host responses to mycobacteria. Front Biosci. 1998;3:e110-e122. Published 1998 Jul 20. doi:10.2741/a371 https://pubmed.ncbi.nlm.nih.gov/9665874/

Feng L, Zheng Y, Liu Y, et al. Hair Zinc and Chromium Levels Were Associated with a Reduced Likelihood of Age Related Cognitive Decline in Centenarians and Oldest-Old Adults. J Nutr Health Aging. 2023;27(11):1012-1017. doi:10.1007/s12603-023-2008-8 https://pubmed.ncbi.nlm.nih.gov/37997723/

Bendellaa, M., Lelièvre, P., Coll, L., Sancey, L., Deniaud, A., & Busser, B. (2024). Roles of zinc in cancers: From altered metabolism to therapeutic applications. International Journal of Cancer, 154(1), 7-20. https://doi.org/10.1002/ijc.34679

Zhou, B., Wang, C., Huang, Y., Yang, X., Ye, T., Shen, L., Lv, Q., Mao, W., & Zhao, A. (2025). Anticancer effects of zinc ion-mediated DNA demethylation in oesophageal squamous cell carcinoma. Frontiers in Pharmacology, 16, 1559675. https://doi.org/10.3389/fphar.2025.1559675

Hoppe, C., Kutschan, S., Dörfler, J. et al. Zinc as a complementary treatment for cancer patients: a systematic review. Clin Exp Med 21, 297–313 (2021). https://doi.org/10.1007/s10238-020-00677-6

Maywald, M., & Rink, L. (2022). Zinc in Human Health and Infectious Diseases. Biomolecules, 12(12), 1748. https://doi.org/10.3390/biom12121748 

Mulhern SA, Vessey AR, Taylor GL, Magruder LE. Suppression of antibody response by excess dietary zinc exposure during certain stages of ontogeny. Proc Soc Exp Biol Med. 1985;180(3):453-461. doi:10.3181/00379727-180-42202 https://pubmed.ncbi.nlm.nih.gov/3909157/ 

Gibson, R.S. Zinc deficiency and human health: etiology, health consequences, and future solutions. Plant Soil 361, 291–299 (2012). https://doi.org/10.1007/s11104-012-1209-4 

Maywald, M., & Rink, L. (2022). Zinc in Human Health and Infectious Diseases. Biomolecules, 12(12), 1748. https://doi.org/10.3390/biom12121748 

Jeng, S., & Chen, Y. (2022). Association of Zinc with Anemia. Nutrients, 14(22), 4918. https://doi.org/10.3390/nu14224918 

Stiles, L.I., Ferrao, K. & Mehta, K.J. Role of zinc in health and disease. Clin Exp Med 24, 38 (2024). https://doi.org/10.1007/s10238-024-01302-6 

Hedera, P., Peltier, A., Fink, J. K., Wilcock, S., London, Z., & Brewer, G. J. (2009). Myelopolyneuropathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin II. The denture cream is a primary source of excessive zinc. NeuroToxicology, 30(6), 996-999. https://doi.org/10.1016/j.neuro.2009.08.008 

Mahmoud MM, Abuohashish HM, Khairy DA, Bugshan AS, Khan AM, Moothedath MM. Pathogenesis of dysgeusia in COVID-19 patients: a scoping review. Eur Rev Med Pharmacol Sci. 2021;25(2):1114-1134. doi:10.26355/eurrev_202101_24683 https://pubmed.ncbi.nlm.nih.gov/33577069/ 

Harless, W., Crowell, E., & Abraham, J. (2006). Anemia and neutropenia associated with copper deficiency of unclear etiology. American Journal of Hematology, 81(7), 546-549. https://doi.org/10.1002/ajh.20647 

Fosmire, G. (1990). Zinc toxicity. The American Journal of Clinical Nutrition, 51(2), 225-227. https://doi.org/10.1093/ajcn/51.2.225 

Fine, Jonathan M. MD; Gordon, Terry PhD; Chen, Lung Chi PhD; Kinney, Patrick PhD; Falcone, Gary; Beckett, William S. MD, MPH. Metal Fume Fever: Characterization of Clinical and Plasma IL-6 Responses in Controlled Human Exposures to Zinc Oxide Fume at and Below the Threshold Limit Value. Journal of Occupational & Environmental Medicine 39(8):p 722-726, August 1997.  https://journals.lww.com/joem/fulltext/1997/08000/Metal_Fume_Fever__Characterization_of_Clinical_and.6.aspx